Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/QNRX/Total liabilities

Quoin Pharmaceuticals Ltd. (QNRX) Total liabilities 2020–2021

Quoin Pharmaceuticals Ltd. (QNRX) total liabilities at each fiscal year-end, per SEC filings.

$8.7MFY2021 · since FY2020: $8.0M → $8.7M
2021
Fiscal yearValueYoY
FY2021$8.7M+9.0%
FY2020$8.0M—

Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.

Source: SEC XBRL filings · For reference only · Not investment advice

More QNRX financial trends

QNRX RevenueQNRX Net incomeQNRX Net marginQNRX Gross profitQNRX Gross marginQNRX Operating incomeQNRX Operating marginQNRX Operating cash flowQNRX Free cash flowQNRX Capital expendituresQNRX Return on equityQNRX Stock buybacksQNRX Dividends paidQNRX Total assetsQNRX Shareholders’ equityQNRX overview →